NSE ScannerChemicals · Chemicals: Specialty · NSE: SRHHYPOLTD · data 2026-11-01
Sree Rayalaseema Hi-Strength Hypo Limited
In plain words
Price: 27.6% below its 52-week high of ₹670.
Delivery: 60.1% of traded shares were kept for delivery over the last 10 sessions, against 63.0% over the last 60.
Latest results: a net profit of ₹25 cr for the quarter ended Jun 2026 (+11.4% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹698 cr |
| Net profit (last 12 months) | ₹92 cr |
| Sales growth, 3 years (yearly) | -26.0% |
| Profit growth, 3 years (yearly) | -16.0% |
At a glance
Promoters 62.2% (+0.3 pts in a year), pledged 0.0%, institutions 0.3%.
P/E 9.1, dividend yield 0.6%. Price relative to earnings and book value (low is cheaper, not better).
ROE 9.7%, ROCE 8.2%, operating margin 11.9%: how much profit it earns on the money it uses.
Debt/equity 0.01, Profit growth -16.0% and sales growth -26.0% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Virtually debt-free (debt/equity 0.1 or less).
- Profit fell 16.0% a year over 3 years.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q1 FY27)
SRHHYPOLTD Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹210.95 crore, up 17% YoY and up 29.3% QoQ.
Net profit was ₹24.96 crore, up 11.4% YoY and up 24.4% QoQ.
Operating margin was 14.2% (15.5% a year ago).
EPS was ₹14.53, up 11.3% YoY and up 22.8% QoQ.
SRHHYPOLTD के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹210.95 करोड़; पिछले साल की तुलना में 17% की बढ़त, पिछली तिमाही की तुलना में 29.3% की बढ़त।
शुद्ध मुनाफ़ा: ₹24.96 करोड़; पिछले साल की तुलना में 11.4% की बढ़त, पिछली तिमाही की तुलना में 24.4% की बढ़त।
ऑपरेटिंग मार्जिन: 14.2% (एक साल पहले 15.5%)।
EPS: ₹14.53; पिछले साल की तुलना में 11.3% की बढ़त, पिछली तिमाही की तुलना में 22.8% की बढ़त।
SRHHYPOLTDના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹210.95 કરોડ; ગયા વર્ષની સરખામણીએ 17% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 29.3% વધારો.
ચોખ્ખો નફો: ₹24.96 કરોડ; ગયા વર્ષની સરખામણીએ 11.4% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 24.4% વધારો.
ઓપરેટિંગ માર્જિન: 14.2% (એક વર્ષ પહેલાં 15.5%).
EPS: ₹14.53; ગયા વર્ષની સરખામણીએ 11.3% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 22.8% વધારો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
9/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 4/30: Delivery 57.8% over the last 20 sessions vs 51.1% in the 40 before (1.13x); shares delivered per day 0.45x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Dividend ● Results
- 18 Sept 26Dividend Dividend ₹3 (ex-date) +21.3% next session
- 12 Aug 26Results Q1 FY27 results: profit +11.4% YoY -1.4% next session
- 30 May 26Results Q4 FY26 results: net profit ₹20.1 cr -7.2% next session
- 14 Feb 26Results Q3 FY26 results: profit +10.2% YoY -0.7% next session
- 13 Nov 25Results Q2 FY26 results: profit −7.9% YoY -4.4% next session
- 19 Sept 25Dividend Dividend ₹3 (ex-date) +1.1% next session
- 14 Aug 25Results Q1 FY26 results: profit +20.4% YoY +1.1% next session
- 15 Feb 25Results Q3 FY25 results: profit +29.6% YoY -9.6% next session
- 15 Nov 24Results Q2 FY25 results: profit +36.9% YoY -2.1% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹211 cr | ₹25 cr | +11.4% | 14.2% | 14.53 |
| Mar 2026 | ₹163 cr | ₹20 cr | — | 8.1% | 11.83 |
| Dec 2025 | ₹141 cr | ₹24 cr | +10.2% | 14.4% | 14.16 |
| Sept 2025 | ₹182 cr | ₹23 cr | -7.9% | 14.8% | 13.57 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 62.19% | 61.84% | 61.84% | 60.45% |
| Foreign institutions (FII) | 0.30% | 0.06% | 0.06% | 0.06% |
| Domestic institutions (DII) | 0.05% | 0.05% | 0.05% | 0.05% |
| Mutual funds | 0.01% | 0.01% | 0.01% | 0.01% |
| Retail investors | 21.04% | 21.63% | 22.03% | 22.17% |
| Number of shareholders | 39,723 | 40,125 | 41,806 | 42,527 |
Common questions
What was Sree Rayalaseema Hi-Strength Hypo Limited's latest quarterly profit?
Sree Rayalaseema Hi-Strength Hypo Limited reported a net profit of ₹25 cr for the quarter ended Jun 2026 (+11.4% on the same quarter a year earlier), on revenue of ₹211 cr.
How much do promoters hold in Sree Rayalaseema Hi-Strength Hypo Limited?
Promoters held 62.19% of Sree Rayalaseema Hi-Strength Hypo Limited at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Sree Rayalaseema Hi-Strength Hypo Limited debt-free?
Its latest reported debt-to-equity ratio is 0.01, which is very low.
What is Sree Rayalaseema Hi-Strength Hypo Limited's P/E ratio?
About 9.1, based on the last 12 months' earnings and a price of ₹485.2 (data 2026-11-01).
What is the 52-week high and low of Sree Rayalaseema Hi-Strength Hypo Limited?
The 52-week high is ₹670 and the 52-week low is ₹382.4.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Sree Rayalaseema Hi-Strength Hypo Limited | ₹485.2 | ₹834 cr | 9.1 | — | 9.7% | 8.2% | 0.01 | -13.0% |
| OCCL Limited | ₹168.27 | ₹836 cr | 11.2 | — | 11.5% | 14.1% | 0.21 | +24.3% |
| Fairchem Organics Ltd | ₹636.15 | ₹800 cr | 33.8 | 2.8 | 2% | 3.6% | 0.32 | -14.9% |
| Amines & Plasticizers Ltd. | ₹142.22 | ₹787 cr | 20.3 | — | 13.3% | 18.3% | 0.09 | -35.6% |
| Kanoria Chemicals & Industries Ltd | ₹167.34 | ₹738 cr | 12.8 | — | 7.3% | 4.2% | 0.51 | +112.8% |
| Kronox Lab Sciences Limited | ₹186.26 | ₹698 cr | 24.2 | — | 26.8% | 31.6% | 0.01 | +22.8% |
Compare SRHHYPOLTD with OCCLLTD in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SRHHYPOLTD in NSE Scanner →